Are There Specific Microbial Biomarkers That Predict Individual Responses to GLP-1 Agonist Therapy?
Microbial biomarkers offer a path to personalize GLP-1 agonist therapy, optimizing metabolic outcomes through gut ecosystem insights.
HRTioJuly 20, 2025